Connect with us
Prague Gaming & TECH Summit 2024

Artificial Intelligence

Oral Sprays to Hold Around 35% Revenue Share in Artificial Saliva Market: Fact.MR Study

Published

on

United States, Rockville, MD, May 02, 2022 (GLOBE NEWSWIRE) — Detailed industry analysis by Fact.MR, a market research and competitive intelligence provider, reveals that the global artificial saliva market is expected to surge ahead at a CAGR of 13.3% reaching US$ 1.4 Bn by the end of 2026.

Artificial saliva is a saliva substitute that partially hydrates and nourishes the mouth while also forming a protective coating that decreases the risk of mechanical damage caused by chronic dry mouth.

Oral sprays and gels can work for up to two hours, but many users find that they need to apply them more frequently to keep their mouth wet, which can disrupt a good night’s sleep and everyday activities. However, as oral gels and liquids are simple to use, demand for artificial saliva is rising rapidly across the world.

Rising prevalence of dry mouth syndrome and dysphagia, rapid deployment of OTC artificial saliva products, and increased adoption of oral sprays, gels, and liquids are all driving market growth.

Request a sample to get extensive insights into the Artificial Saliva Oral Sprays Demand Report at

https://www.factmr.com/connectus/sample?flag=S&rep_id=7297

Key Takeaways from Market Study

  • Global artificial saliva market to reach US$ 1.4 Bn valuation by 2026.
  • Oral sprays expected to reach around US$ 579.2 Mn by 2026-end.
  • Oral solutions projected to record 12.6% CAGR from 2021 to 2026
  • Market in Europe to record 9.6% CAGR over forecast period (2022-2026).

Growing interest of the pharmaceutical industry in developing medications in a variety of forms will help broaden product pipeline. Artificial saliva product manufacturers will benefit from a solid product pipeline and increased research and development operations,” says a Fact.MR analyst

Winning Strategy

To expand their regional presence, key manufacturers of artificial saliva are focused on expanding their product portfolios, acquiring developing players, and entering into distribution agreements. Due to increased demand for artificial saliva products, key providers are concentrating on diversifying their portfolios to survive in this environment.

Major players are focusing on acquiring new businesses and launching programs to raise awareness about dry mouth conditions. Customers are more likely to buy products from well-known companies, and thus, key players are working on strengthening their brands.

For instance,

  • In September 2021, ICPA Health Products (ICPA) launched Wet Mouth, a saliva alternative for people who suffer from xerostomia and dysphagia.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Artificial Saliva Oral Solutions Demand Market at https://www.factmr.com/connectus/sample?flag=RC&rep_id=7297

Key Segments Covered in Artificial Saliva Industry Research

  • Artificial Saliva Market by Product :
    • Oral Sprays
    • Oral Solutions
    • Oral Liquids
    • Gels
    • Powders
  • Artificial Saliva Market by Age Group :
    • Adults
    • Paediatrics
  • Artificial Saliva Market by Distribution Channel :
    • Hospital Pharmacies
    • Retail Pharmacies
    • Mail Order Pharmacies
    • Hypermarkets and Supermarkets
  • Artificial Saliva Treatment Market by Region :
    • North America Artificial Saliva Market
    • Europe Artificial Saliva Market
    • Asia Pacific Artificial Saliva Market
    • Latin America Artificial Saliva Market
    • MEA Artificial Saliva Market

Get a glimpse of the in-depth analysis through our Artificial Saliva Oral Liquids Demand Report at https://www.factmr.com/checkout/7297

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the global artificial saliva market, presenting historical demand data (2017-2020) and forecast statistics for the period of 2021-2026.

The study divulges essential insights on the market on the basis of product (oral sprays, oral solutions, oral liquids, gels, and powders), age group (adults and paediatrics), and distribution channel (hospital pharmacies, retail pharmacies, mail order pharmacies, and hypermarkets and supermarkets), across five major regions (North America, Europe, Asia Pacific, Latin America, and MEA).

Fact.MR’s Domain Knowledge in Healthcare        

Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support – encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.

To learn more about Sales of Artificial Saliva, you can get in touch with our Analyst at

https://www.factmr.com/connectus/sample?flag=AE&rep_id=7297

Check out more studies related to Healthcare Industry, conducted by Fact.MR:

Which Market Growth Trends are Driving Consumption of Vancomycin? – The global vancomycin industry is growing as antibiotic consumption rises in low- and middle-income nations, with pharmaceutical companies investing heavily in research and development, besides the rising prevalence of infectious diseases.

How are Lifestyle Changes Affecting CNS Therapeutics Market Potential? – Lifestyle habits have changed drastically over the past few years and this has largely affected the overall health trends of the general population and given rise to multiple diseases owing to poor lifestyle choices.

Which Key Market Contributors are Driving Demand for Ulcerative Colitis Therapeutics? – Increased demand for symptomatic treatments, the influx of enhancing medications into the market, and increased acceptance of steroids and biologics to treat ulcerative colitis are all contributing to the industry growth.

How is Osteoporosis Therapeutics Market Growth Being Hindered? – All drugs have to undergo an approval procedure by respective regulatory authorities of their regions in order to be commercialized and available for patients and healthcare professionals.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

Mahendra Singh

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

Email: [email protected]

Tel: +1 (628) 251-1583

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

XtalPi Unveils XtalGazer: A Comprehensive AI-Driven Polymorph Selection Platform

Published

on

xtalpi-unveils-xtalgazer:-a-comprehensive-ai-driven-polymorph-selection-platform

CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ — XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid form discovery and selection platform, XtalGazer. This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.

XtalGazer provides a total solution for delivering high-quality polymorph screening and selection methods to expedite drug development and mitigate risks. It represents a paradigm shift in solid-state research, moving from the traditional trial-and-error approach to a data-driven, design-led methodology. The platform provides an expansive suite of foundational tools to accelerate polymorph discovery, characterization, and selection process, empowering pharmaceutical companies to conduct thorough research with less active pharmaceutical ingredient (API) in shorter development cycles.
A key component of XtalGazer is XtalCSP, a crystal structure prediction platform to perform global searches of crystal structures for target molecules and the other optional components in the corresponding searching space, offering a deep insight into possible stable forms. Furthermore, crystallization strategy recommendations will provide AI-backed experimental design to help avoid human bias. XtalGazer also utilizes MicroED to rapidly elucidate crystal structures from powder samples, reducing the need for growing single crystals.
XtalPi’s launch of XtalGazer marks another significant step in the company’s ongoing exploration of solid-state research. From crystal structure prediction platforms being one of the first products to launch at XtalPi, to today’s comprehensive polymorph selection platform, XtalPi will keep fulfilling its promise to solving challenging problems in this space. XtalPi will continue to deliver faster, more accurate, and more comprehensive approaches to building an ecosystem for the R&D process in solid-state, pre-formulation and crystallization.
For more information about XtalPi, please visit www.xtalpi.com.
About XtalPi:
XtalPi is an innovative technology company powered by artificial intelligence (AI) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving intelligent and digital transformation in the life science and new materials industries. With tightly interwoven quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of technology solutions, services, and products to accelerate and empower innovation for biopharmaceutical and new materials companies worldwide.
Media Contact: Vivienne [email protected]
Logo – https://mma.prnewswire.com/media/632519/XtalPi_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/xtalpi-unveils-xtalgazer-a-comprehensive-ai-driven-polymorph-selection-platform-302102794.html

Continue Reading

Artificial Intelligence

ICIS and Base Oil News Announce Partnership to Enhance Market Insights

Published

on

icis-and-base-oil-news-announce-partnership-to-enhance-market-insights

LONDON, March 28, 2024 /PRNewswire/ — ICIS, a global source of commodity intelligence, is pleased to announce a strategic partnership with Base Oil News, a premier news outlet founded by industry expert Iain Pocock that provides in-depth coverage of the base oils and lubricants market. This collaboration marks a significant milestone in the dissemination and exchange of critical market data and insights.

With more than two decades of journalism experience at Bloomberg, Reuters, and Argus Media, Iain Pocock brings unparalleled expertise to this partnership. His deep understanding of illiquid energy markets makes him a credible and influential figure in the industry. Since November 2023, Iain has been working closely with ICIS to share and exchange valuable data and insights, enhancing the services both platforms offer to the base oils and lubricants market.
Through the collaboration, Iain integrates ICIS’ extensive content and data resources in Base Oil News market coverage. In return, he contributes market insights to ICIS News, including expert and exclusive analysis of supply and demand dynamics, price margins, and other critical market drivers. This exchange ensures that subscribers of both ICIS and Base Oil News have access to the most comprehensive, timely, and accurate market information, empowering them to make informed decisions.
“It’s a very exciting partnership – where we leverage each other’s strengths and provide actionable insights to our customers,” said Iain Pocock, Founder of Base Oil News. “The market is the winner.”
“As ICIS is already the world’s most trusted pricing benchmark for base oils, this collaboration with Iain Pocock and Base Oil News provides an even stronger and deeper service to our customers,” said Stephen Burns, Editorial Director at ICIS. “Iain’s expertise and extensive industry connections are invaluable, and we have established a fruitful partnership that benefits the market at large.”
For the latest insights from Iain Pocock on ICIS News, visit ICIS News.  
About ICIS
ICIS – Independent Commodity Intelligence Services – helps businesses through seamlessly delivering data and analytics, across the chemical, fertilizer and energy markets. A trusted source and benchmark for price information and insight across key commodities markets worldwide. Our independent, transparent market intelligence informs thousands of quality decisions every day, taking the pressure out of negotiations and giving customers space for more innovative thinking, through published datasets including price assessments, price forecasts, supply and demand fundamentals and more.
Over 150 years of shaping the world by connecting markets to optimise the world’s valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.
ICIS is part of RELX, a FTSE15 company with a market cap of £64bn and an employee base of over 30,000 experts across 40 countries.
About RELX
RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £64bn | €75bn | $81bn.
Logo: https://mma.prnewswire.com/media/619935/4277787/ICIS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/icis-and-base-oil-news-announce-partnership-to-enhance-market-insights-302102782.html

Continue Reading

Artificial Intelligence

Trianz Welcomes Israel Abraham as Vice President of Services for Extrica.ai – The Data to AI Platform

Published

on

trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extrica.ai-–-the-data-to-ai-platform

SANTA CLARA, Calif., March 28, 2024 /PRNewswire/ — Digital transformation technology & services company Trianz is pleased to announce the appointment of Israel Abraham as Vice President of Extrica Platform Services.

Trianz has embarked on a transformative journey, redefining its value proposition with an ‘IP Led’ model, with a commitment to deliver the fastest time to value, lowest human dependence, and highest ROI. Central to this approach are our hyper-automated platforms, Concierto.Cloud, Extrica.AI, and Pulse, driving industry-leading transformations in cloud, data and analytics, AI, and the digital workplace.
Israel Abraham is a very well-known pioneer and industry leader in AI, data management, and analytics systems, with over three decades of experience. He joins as the services leader for Extrica- the Trianz Data to AI platform, which productizes data, provides data a face and purpose, and accelerates time to insights and AI by 50% or more. In the role of Extrica Services leader, Israel will lead the shaping, visioning, and delivery of Extrica.ai based enterprise wide datamesh, BI, and AI solutions for customers worldwide.
“We are thrilled to welcome Israel Abraham to the Trianz family,” said Sri Manchala, CEO of Trianz and author of Crossing the Digital Faultline. “He is a leader in modernization as well as conceptualization of data platforms anew. Israel’s prior background in the industry with financial services and insurance giants underscores our commitment to securing top-tier talent that brings real-world experiences and needs to our technology platforms. As we continue to broaden our footprint in the digital transformation space, Israel’s visionary leadership and practical experience will serve as the cornerstone in accelerating insights and AI to deliver transformative value to our clients.”
Having played pivotal roles in highly reputed and large organizations such as Liberty Mutual Insurance, MassMutual, Safeco, and CNA Insurance, Israel has garnered recognition as a seasoned leader in big data and AI cloud implementations. His accolades include the prestigious 2014 Ventana Research IT Innovation Award, the 2009 Informatica MDM Innovation Award, and three filed Data Engineering patents in the last four years.
“Trianz has been at the forefront of digital innovation, and Extrica.ai is a paradigm shifting data to AI platform that completely changes how analytics and AI are delivered- much faster, taking business ahead of change. I am excited to scale the adoption of the Extrica platform, which has attracted attention from giants across the industry and hyperscalers,” said Israel Abraham. “I look forward to engaging with customers, bringing my own experiences, and collaborating with the talented team at Trianz to further enhance the capabilities of the Extrica Platform Services to transform data & AI strategies, execution, and outcomes for customers.”
About Trianz
Trianz is a leading-edge technology platforms and services company that accelerates digital transformations at Fortune 100 and emerging companies worldwide in data & analytics, digital experiences, cloud infrastructure, and security. Our ‘IP Led Transformations’ approach, informed by insights from a recent global study spanning 20+ industries and 5000+ companies, addresses challenges posed by the rapid pace of AI-driven transformation, digital talent scarcity, and economic uncertainty. Our IP and platforms, including Concierto, Extrica, and Pulse, revolutionize cloud adoption, data analytics, and AI insights, empowering organizations to navigate the complexities of digital transformation seamlessly.
Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz is a Premier Partner of AWS, consistently rated #1 by clients for value delivery over the past five years. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit www.trianz.com.
Watch Trianz CEO Sri Manchala’s insightful interview with Bloomberg on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube and delve deeper into his book Crossing the Digital Faultline at Crossing the Digital Faultline | Trianz.
Trianz Media [email protected] +1-408-387-5800
Logo: https://mma.prnewswire.com/media/626944/1199800/Trianz_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extricaai–the-data-to-ai-platform-302102589.html

Continue Reading

Trending